Clinical studies involving a wider patient cohort is warranted to confirm the findings from preclinical studies
BPC-157 is not FDA-approved and should be used under physician supervision with pharmaceutical-grade peptides from licensed compounding pharmacies which is exactly how Beyond Stem Cells delivers it in Littleton, CO
Hare DJ, Kysenius K, Paul B, Knauer B, Hutchinson RW, OConnor C, Fryer F, Hennessey TP, Bush AI, Crouch PJ, Doble PA
ATB-737 and navitoclax are pan-BCL inhibitors targeting the BCL-2/W/XL family of anti-apoptotic guardians [25, 26], while quercetin is a natural product with anticancer properties that acts on various pathways implicated in diverse biological processes [27]
doi: 10.1073/pnas.1321232111 22 KimuraYKoikeSShibuyaNLeferDOgasawaraYKimuraH
it has to produce and recycle it